Medical Inventory from 2010 to 2024

MPW Stock  USD 4.33  0.07  1.64%   
Medical Properties Inventory yearly trend continues to be fairly stable with very little volatility. Inventory is likely to outpace its year average in 2024. During the period from 2010 to 2024, Medical Properties Inventory regression line of quarterly data had mean square error of 354337.9 T and geometric mean of 0.00. View All Fundamentals
 
Inventory  
First Reported
2011-03-31
Previous Quarter
-43 M
Current Value
1
Quarterly Volatility
414.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medical Properties financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Properties' main balance sheet or income statement drivers, such as Depreciation And Amortization of 633.5 M, Interest Expense of 390.6 M or Selling General Administrative of 152.9 M, as well as many indicators such as Price To Sales Ratio of 3.2, Dividend Yield of 0.22 or PTB Ratio of 0.37. Medical financial statements analysis is a perfect complement when working with Medical Properties Valuation or Volatility modules.
  
Check out the analysis of Medical Properties Correlation against competitors.

Latest Medical Properties' Inventory Growth Pattern

Below is the plot of the Inventory of Medical Properties Trust over the last few years. It is Medical Properties' Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medical Properties' overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Pretty Stable
   Inventory   
       Timeline  

Medical Inventory Regression Statistics

Arithmetic Mean155,837,905
Geometric Mean0.00
Coefficient Of Variation371.18
Mean Deviation368,023,492
Median(27,028,000)
Standard Deviation578,440,933
Sample Variance334593.9T
Range2.1B
R-Value0.13
Mean Square Error354337.9T
R-Squared0.02
Significance0.65
Slope16,682,128
Total Sum of Squares4684314.8T

Medical Inventory History

2024-142 M
2023-149.5 M
2022-304.5 M
20211.2 B
2020 1.0
20191.8 B
2018-61.8 M

Other Fundumenentals of Medical Properties Trust

Medical Properties Inventory component correlations

About Medical Properties Financial Statements

Medical Properties investors use historical fundamental indicators, such as Medical Properties' Inventory, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medical Properties. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Inventory-149.5 M-142 M
Change To Inventory133.9 M140.6 M
Inventory Turnover(0.17)(0.16)
Days Of Inventory On Hand-2.8 K-2.7 K
Average Inventory559.8 M328.9 M
Days Of Inventory Outstanding-2.8 K-2.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medical Stock Analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.